# A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Study · id `cardio:ct-nct01614652` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01614652](<https://clinicaltrials.gov/study/NCT01614652>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01614652

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 331 participants.

## Technical summary

Registry record NCT01614652. Randomized; no masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2017-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 331 participants (enrolled count; ClinicalTrials.gov record NCT01614652, source copy `cardio:ctgov-nct01614652-2017-06-23`, retrieved 2026-10-26)
- Start date: 2012-12 (registry gives no type) (ClinicalTrials.gov record NCT01614652, source copy `cardio:ctgov-nct01614652-2017-06-23`, retrieved 2026-10-26)
- Primary completion: 2017-06 (actual) (ClinicalTrials.gov record NCT01614652, source copy `cardio:ctgov-nct01614652-2017-06-23`, retrieved 2026-10-26)
- Completion: 2017-06 (actual) (ClinicalTrials.gov record NCT01614652, source copy `cardio:ctgov-nct01614652-2017-06-23`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT01614652, source copy `cardio:ctgov-nct01614652-2017-06-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01614652-2017-06-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System
- Acronym: PARACHUTE IV
- Condition: Congestive Heart Failure
- Condition: Left Ventricular (LV) Systolic Dysfunction
- Intervention (Device): CardioKinetix Parachute Implant and All Appropriate Medical Therapy (AAMT)
- Lead sponsor: CardioKinetix, Inc
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 1a0eda6f05b193c6416f752846d8bf4efc5ed763095d56a14bd8ece99597b214
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
